Semax: the nootropic peptide, explained

A synthetic peptide from a brain-signaling hormone, developed in Russia and studied for focus and cognition.

TL;DR

• Semax is a synthetic peptide derived from a fragment of ACTH (adrenocorticotropic hormone — the brain's primary stress-signaling molecule).
• Early research, mostly in animals, links it to BDNF (brain-derived neurotrophic factor — a protein that helps brain cells grow and connect).
• Semax is not an FDA-approved drug in the US and is currently classified as Category 2, which limits how it can be compounded.

What it is

Semax is a short synthetic peptide — just seven amino acids (the building blocks of protein) long. It was developed in Russia in the 1980s and is based on a fragment of ACTH (adrenocorticotropic hormone — the body's stress-signaling molecule made by the brain's pituitary gland). Researchers added a small tail to that fragment to make it more stable in the body. The result is a molecule that acts like a key shaped to fit certain brain receptors. It is not a natural substance and it is not an FDA-approved drug.

How it works

Think of your brain cells as having an inbox for certain chemical messages. Semax appears to open that inbox — early research in animals shows it prompts the brain to produce more BDNF (brain-derived neurotrophic factor, in plain English: a protein that acts like fertilizer for brain cells, helping them grow, connect, and survive). A 2004 study found Semax raised BDNF gene expression in rat brain tissue (Dolotov et al., 2006). Research also links it to activity in dopamine (the motivation chemical) and serotonin (the mood chemical) systems. Most of this data comes from rodents, not humans.

Who asks about it

People come to Semax after reading about nootropics — compounds studied in the context of memory, focus, or brain health. Many have already heard about it in online communities and want a plain-language explanation of what it is, how it differs from common supplements, and whether it is accessible through a medical channel in the United States.

What the research says

The published literature on Semax is real but mostly preclinical — meaning it comes from cell studies and animal models. A key 2004 paper (PMID 14556513) showed Semax stimulated BDNF expression in rat hippocampal and cortical tissue — regions involved in learning and memory (Dolotov et al., 2004). A separate study found it activated dopaminergic and serotonergic systems in rodents. Human clinical trials are limited and mostly Russian-language, which makes peer review difficult for Western scientists. Early research suggests interest; it does not establish what Semax does in healthy adults.

What to know before considering it

Semax is not available as an FDA-approved drug in the US. As of early 2026, the FDA placed it in Category 2 — meaning 503A compounding pharmacies (the licensed pharmacies that prepare custom medications for patients) cannot compound it. Any access requires a licensed clinician, a legal pharmacy pathway, and a prescription. Do not source it from unregulated vendors.

The Halftime POV

Semax sits at the edge of what we can discuss and what we can prescribe. The science is early and interesting. The US regulatory status is in motion — a February 2026 HHS proposal could change Category 2 status. We are watching it closely. When the rules allow and the evidence supports it, our clinicians will be ready to evaluate it with you. Until then, we will keep explaining the science as clearly as we can.

Related reading:

• What is a peptide?
• Receptor specificity: how targeted peptides work
• Why peptides are still Category 2
• Sleep quality and aging research

---

FAQ

Q: What is Semax? A: Semax is a synthetic peptide derived from a fragment of ACTH (adrenocorticotropic hormone — the brain's stress-signaling hormone). It was developed in Russia and has been studied in the context of cognition and neuroprotection, primarily in animal models.

Q: How does Semax work? A: Early research suggests Semax influences the expression of BDNF (brain-derived neurotrophic factor — a protein that helps brain cells grow and form connections). It has also been studied for effects on dopamine and serotonin activity in rodents.

Q: Is Semax legal in the US? A: Semax is not an FDA-approved drug in the United States. As of early 2026, the FDA classified Semax as a Category 2 substance, meaning it is not currently available from 503A compounding pharmacies. A February 2026 HHS announcement proposed returning certain peptides, including Semax, to Category 1 pending formal FDA notice.

Q: Can I get Semax through Halftime Health? A: Not currently. Halftime Health only prescribes through licensed clinicians in states where our partner physicians are credentialed, and only substances that are legally available through our pharmacy partners. We will update members as the regulatory picture evolves.

---

Disclaimer

As of 2027-01-23, several peptides discussed in this article — including Semax — are classified by the FDA as Category 2, which means they are not currently available from 503A compounding pharmacies. A February 2026 HHS announcement proposed returning these peptides to Category 1 pending formal FDA Federal Register notice. This article is educational and is not medical advice. Halftime Health only prescribes through licensed clinicians in states where our partner physicians are credentialed.

Get updates

Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.

---

Sources

• Dolotov OV et al., "The heptapeptide SEMAX stimulates BDNF expression in different rat brain structures," Neuroscience Letters (2004)
• Manchenko DM et al., "Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents," Neuroscience and Behavioral Physiology (2006)

---